More Support for Biotech ETFs as Value Plays

With investors searching for sectors that look like legitimate value plays and discovering fewer and fewer options, a surprising group is being deemed a value proposition: Biotechnology stocks and exchange traded funds. Rare are the occasions that biotechnology stocks and exchange traded funds are...